These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22038904)

  • 1. Sensitive single-molecule protein quantification and protein complex detection in a microarray format.
    Tessler LA; Mitra RD
    Proteomics; 2011 Dec; 11(24):4731-5. PubMed ID: 22038904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute quantification of protein copy number using a single-molecule-sensitive microarray.
    Burgin E; Salehi-Reyhani A; Barclay M; Brown A; Kaplinsky J; Novakova M; Neil MA; Ces O; Willison KR; Klug DR
    Analyst; 2014 Jul; 139(13):3235-44. PubMed ID: 24676423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays.
    Ramalingam S; Honkanen P; Young L; Shimura T; Austin J; Steeg PS; Nishizuka S
    Cancer Res; 2007 Jul; 67(13):6247-52. PubMed ID: 17616682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-channel surface plasmon resonance monitoring of intracellular levels of the p53-MDM2 complex and caspase-3 induced by MDM2 antagonist Nutlin-3.
    Wu L; Hu Y; He Y; Xia Y; Lu H; Cao Z; Yi X; Wang J
    Analyst; 2019 Jul; 144(13):3959-3966. PubMed ID: 31134974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive and simultaneous surface plasmon resonance detection of free and p53-bound MDM2 proteins from human sarcomas.
    Wu L; Tang H; Hu S; Xia Y; Lu Z; Fan Y; Wang Z; Yi X; Zhou F; Wang J
    Analyst; 2018 Apr; 143(9):2029-2034. PubMed ID: 29637949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/MS-based targeted proteomics quantitatively detects the interaction between p53 and MDM2 in breast cancer.
    Zhang W; Zhong T; Chen Y
    J Proteomics; 2017 Jan; 152():172-180. PubMed ID: 27826076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction between p53 and MDM2 in human lung cancer cells].
    Rybárová S; Hodorová I; Vecanová J; Muri J; Mihalik J
    Klin Onkol; 2014; 27(1):33-7. PubMed ID: 24635435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of p53-MDM2 auto-regulatory pathway in breast carcinoma.
    Baliou E; Nonni A; Keramopoulos D; Ragos V; Tsiambas E; Patsouris E; Pavlakis K
    J BUON; 2016; 21(5):1099-1103. PubMed ID: 27837610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical-free lysis and fractionation of cells by use of surface acoustic waves for sensitive protein assays.
    Salehi-Reyhani A; Gesellchen F; Mampallil D; Wilson R; Reboud J; Ces O; Willison KR; Cooper JM; Klug DR
    Anal Chem; 2015 Feb; 87(4):2161-9. PubMed ID: 25514590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selected immunohistochemical features of conventional renal cell carcinomas coexpressing P53 and MDM2.
    Hejnold M; Dyduch G; Białas M; Demczuk S; Ryś J; Chłosta P; Szopiński T; Okoń K
    Pol J Pathol; 2014 Jun; 65(2):113-9. PubMed ID: 25119170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native PAGE to study the interaction between the oncosuppressor p53 and its protein ligands.
    Lamberti A; Sgammato R; Desiderio D; Punzo C; Raimo G; Novellino E; Carotenuto A; Masullo M
    Electrophoresis; 2015 Feb; 36(4):552-5. PubMed ID: 25363585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept.
    Das P; Jain D; Vaiphei K; Wig JD
    Dig Dis Sci; 2008 Aug; 53(8):2183-8. PubMed ID: 18080767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional protein microarrays for parallel characterisation of p53 mutants.
    Boutell JM; Hart DJ; Godber BL; Kozlowski RZ; Blackburn JM
    Proteomics; 2004 Jul; 4(7):1950-8. PubMed ID: 15221755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of protein microarray technology to monitor biomarkers of rheumatoid arthritis disease.
    Urbanowska T; Mangialaio S; Hartmann C; Legay F
    Cell Biol Toxicol; 2003 Jun; 19(3):189-202. PubMed ID: 12945746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluorescent probe for imaging p53-MDM2 protein-protein interaction.
    Liu Z; Miao Z; Li J; Fang K; Zhuang C; Du L; Sheng C; Li M
    Chem Biol Drug Des; 2015 Apr; 85(4):411-7. PubMed ID: 25226874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of Mdm2 and p53 in feline mammary gland tumors.
    Nakano M; Wu H; Taura Y; Inoue M
    J Vet Med Sci; 2006 May; 68(5):421-5. PubMed ID: 16757883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the spatial architecture of p53, MDM2, and p14ARF containing complexes.
    Savchenko A; Yurchenko M; Snopok B; Kashuba E
    Mol Biotechnol; 2009 Mar; 41(3):270-7. PubMed ID: 18989794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Reactive Oxygen and Nitrogen Species Produced by Plasma on Mdm2-p53 Complex.
    Attri P; Kurita H; Koga K; Shiratani M
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma.
    Taghavi N; Biramijamal F; Sotoudeh M; Khademi H; Malekzadeh R; Moaven O; Memar B; A'rabi A; Abbaszadegan MR
    BMC Cancer; 2010 Apr; 10():138. PubMed ID: 20388212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust estimation of protein expression ratios with lysate microarray technology.
    Mircean C; Shmulevich I; Cogdell D; Choi W; Jia Y; Tabus I; Hamilton SR; Zhang W
    Bioinformatics; 2005 May; 21(9):1935-42. PubMed ID: 15647295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.